OncoOne Revenue and Competitors
Estimated Revenue & Valuation
- OncoOne's estimated annual revenue is currently $2.8M per year.
- OncoOne's estimated revenue per employee is $155,000
Employee Data
- OncoOne has 18 Employees.
- OncoOne grew their employee count by -10% last year.
OncoOne's People
| Name | Title | Email/Phone |
|---|
OncoOne Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is OncoOne?
OncoOne is a biotech start-up dedicated to develop innovative therapeutics to treat patients with solid tumors.
keywords:N/A
N/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
OncoOne News
2022-04-06 - OncoOne Presents Preclinical Proof of Concept Data for its ...
OncoOne Presents Preclinical Proof of Concept Data for its Next-Generation oxMIF-targeted Monoclonal Antibody ON203 at the AACR Annual Meeting.
Other Companies in Vienna
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.3M | 18 | -25% | N/A |
#2 | $1.6M | 18 | 13% | N/A |
#3 | $0.6M | 18 | -28% | $0.5M |
#4 | $1.6M | 18 | 6% | N/A |
#5 | $2.9M | 18 | -5% | N/A |